Use of IFN Alpha and Amantadine for the treatment of chronic hepatitis C using IFN alpha

摘要

The present Invention provides the use of IFN Alpha in association with Amantadine for the manufacture of medicaments for the treatment of chronic hepatitis C.The present Invention also provides Medicine containing IFN Alpha and Amantadine as a preparacioncombinada for simultaneous use.Separate or Sequential Therapy of chronic infections of hepatitis C.The present Invention also provides a method to treat chronic infections of hepatitis C in patients in need of such treatment, which comprises administering an amount of IFN Alpha.A number of ioncon Amantadine is effective for treating hepatitis C